ArticleDrugs - real world outcomes2019

Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication.

Javier Cid Ruzafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.